News

APHL 2026: Key Highlights and Innovations in Public Health

general · 8 min

APHL 2026 Annual: Day 1 Key Takeaways

general · 6 min

APHL 2026 Annual: Day 1 Highlights & Key Takeaways

general · 8 min

IPEC Annual Meeting: Key Highlights and Industry Insights

general · 6 min

FDLI Annual 2026: Key Regulatory Updates and Industry Trends

general · 8 min

FDLI Annual 2026: Key Regulatory Insights & Policy Updates

general · 8 min

THMA Oncology Forum: Key Insights and Discussions Day 1

oncology · 6 min

Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas

2 min

Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment

2 min

CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis

2 min

Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD

FDA · 2 min

FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer

FDA · 2 min